Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Amortizatization of Intangibles (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $511000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Amortizatization of Intangibles fell 54.42% to $511000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $1.1 million, a 33.94% decrease, with the full-year FY2024 number at $4.0 million, up 280.04% from a year prior.
  • Amortizatization of Intangibles was $511000.0 for Q4 2023 at LENZ Therapeutics, down from $527000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q4 2022 to a low of -$45000.0 in Q1 2022.